Merck nears $6bn biotech deal to boost cancer drug pipeline

By:
On:
URL has been copied successfully!
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here